INNOVATE (VATE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
Annual meeting scheduled for June 11, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 10, 2026.
Voting matters and shareholder proposals
Election of four directors: Avram A. Glazer, Warren H. Gfeller, Brian S. Goldstein, and Amy M. Wilkinson, all recommended by the board.
Advisory vote to approve named executive officer compensation (Say on Pay Vote).
Proposal to amend the 2014 Omnibus Equity Award Plan to increase available shares for issuance.
Ratification of BDO USA, P.C. as independent auditor for fiscal year ending December 31, 2026.
Consideration of any other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Latest events from INNOVATE
- Board recommends FOR all proposals, with focus on growth, governance, and executive alignment.VATE
Proxy filing28 Apr 2026 - Q4 2025 revenue up 61.7% to $382.7M, with strong Infrastructure growth and narrowing net loss.VATE
Q4 202526 Mar 2026 - Q2 net income rose to $14.4M as margins improved and Life Sciences posted record sales.VATE
Q2 20242 Feb 2026 - Q3 revenue dropped 35.5% to $242.2M; growth in Life Sciences and Spectrum, but going concern risk remains.VATE
Q3 202416 Jan 2026 - Revenue declined, but Life Sciences and Spectrum grew; debt reduced and backlog remains strong.VATE
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance after major 2024 changes.VATE
Proxy Filing2 Dec 2025 - Director elections, say-on-pay, and auditor ratification up for vote at June 2025 meeting.VATE
Proxy Filing2 Dec 2025 - Annual meeting adjourned for technical reasons; voting postponed to June 18, 2024.VATE
Proxy Filing2 Dec 2025 - Revenue fell 22.7% to $242M, net loss $22M, Life Sciences grew, major debt refinancing completed.VATE
Q2 202523 Nov 2025